276.61 sec. 001 - Biotechnology Law (Fall 2020)
Instructor: Jennifer A Johnson
Instructor: Barbara Mcclung
View all teaching evaluations for this course - degree students only
Units: 2
Grading Designation: Graded
Due to COVID-19, this class is remote for Fall 2020.
Mode of Instruction: Remote Instruction
Meeting:
M 6:25 PM - 8:15 PM
Location: Internet/Online
From August 17, 2020
To November 23, 2020
Course End: November 23, 2020
Class Number: 32660
Enrollment info:
Enrolled: 13
Waitlisted: 0
Enroll Limit: 36
As of: 12/07 09:41 AM
This course will examine legal issues encountered uniquely and frequently in the biotechnology industry. Particular attention will be given to biotechnology-specific patent issues, technology licensing, litigation, the regulatory landscape for pharmaceuticals and agricultural products, and various hot topics such as the CRISPR-Cas9 patent landscape. The course emphasis is on myriad real-life complexities faced by practitioners in the biosciences.
Barbara McClung is Chief Legal Officer for Caribou Biosciences and Jen Johnson is Associate General Counsel for DuPont's biotechnology business.
Prerequisites:
Introduction to intellectual property and/or patent law course is strongly recommended.
Exam Notes: (TH) Take-home examination
Course Category: Intellectual Property and Technology Law
If you are the instructor or their FSU, you may add a file like a syllabus or a first assignment to this page.
Readers:
No reader.
Books:
Instructor has indicated that no books will be assigned.